Aizen Acquires Patent Rights Related to Vaccine Composition
[Asia Economy Reporter Park Jihwan] iGene announced on the 5th that it has acquired a patent right related to a vaccine composition containing an immune response modulating substance.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The company explained, "This patented technology has the efficacy to enhance not only cellular immunity but also humoral immunity, shows excellent induction of immune responses against specific pathogens, and has outstanding immune-enhancing effects."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
